BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21194444)

  • 21. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
    Willner J; Jost A; Baier K; Flentje M
    Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques.
    Vogelius IS; Westerly DC; Cannon GM; Bentzen SM
    Acta Oncol; 2010 Oct; 49(7):1052-7. PubMed ID: 20831495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic radiotherapy using tomotherapy for early-stage non-small cell lung carcinoma: analysis of intrafraction tumour motion.
    Boggs DH; Feigenberg S; Walter R; Wissing D; Patel B; Wu T; Rosen L
    J Med Imaging Radiat Oncol; 2014 Dec; 58(6):706-13. PubMed ID: 24767098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).
    Cohen MH; Johnson JR; Chattopadhyay S; Tang S; Justice R; Sridhara R; Pazdur R
    Oncologist; 2010; 15(12):1344-51. PubMed ID: 21148614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center experience.
    Figlia V; Mazzola R; Cuccia F; Alongi F; Mortellaro G; Cespuglio D; Cucchiara T; Iacoviello G; Valenti V; Molino M; Verderame F; Matranga D; Casto AL; Ferrera G
    Radiol Med; 2018 Jun; 123(6):406-414. PubMed ID: 29455424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pembrolizumab combined with stereotactic body radiotherapy in a patient with human immunodeficiency virus and advanced non-small cell lung cancer: a case report.
    Li D; He C; Xia Y; Du Y; Zhang J
    J Med Case Rep; 2018 Apr; 12(1):104. PubMed ID: 29681240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis.
    Aibe N; Yamazaki H; Nakamura S; Tsubokura T; Kobayashi K; Kodani N; Nishimura T; Okabe H; Yamada K
    J Radiat Res; 2014 May; 55(3):575-82. PubMed ID: 24457315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis.
    Casutt A; Bouchaab H; Beigelman-Aubry C; Bourhis J; Lovis A; Matzinger O
    Br J Radiol; 2015 May; 88(1049):20140687. PubMed ID: 25735428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
    Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
    Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
    Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
    Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patients.
    Dworzecki T; Idasiak A; Syguła D; Dworzecka U; Suwiński R
    Neoplasma; 2012; 59(1):114-20. PubMed ID: 22103905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial.
    Miyamoto S; Azuma K; Ishii H; Bessho A; Hosokawa S; Fukamatsu N; Kunitoh H; Ishii M; Tanaka H; Aono H; Nakahara Y; Kusaka K; Hosomi Y; Kikuchi N; Mori Y; Itani H; Hamada A; Yamada K; Okamoto H
    JAMA Oncol; 2020 Jul; 6(7):e201250. PubMed ID: 32407455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation-induced lung damage in patients treated with stereotactic body radiotherapy after EGFR-TKIs: is there any difference from stereotactic body radiotherapy alone?
    Tang X; Shen Y; Meng Y; Hou L; Zhou C; Yu C; Jia H; Wang W; Ren G; Cai J; Li XA; Yang H; Kong FS
    Ann Palliat Med; 2021 Mar; 10(3):2832-2842. PubMed ID: 33548998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
    Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
    Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of radiation recall pneumonitis induced by erlotinib, which can be related to high plasma concentration.
    Togashi Y; Masago K; Mishima M; Fukudo M; Inui K
    J Thorac Oncol; 2010 Jun; 5(6):924-5. PubMed ID: 20502274
    [No Abstract]   [Full Text] [Related]  

  • 38. Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.
    Rosen LR; Fischer-Valuck BW; Katz SR; Durci M; Wu HT; Syh J; Syh J; Patel B
    Tumori; 2014; 100(1):42-8. PubMed ID: 24675490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review.
    Rodríguez-Ruiz ME; San Miguel I; Gil-Bazo I; Perez-Gracia JL; Arbea L; Moreno-Jimenez M; Aristu J
    Radiat Oncol; 2012 Mar; 7():50. PubMed ID: 22455311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary toxicity associated with erlotinib.
    Liu V; White DA; Zakowski MF; Travis W; Kris MG; Ginsberg MS; Miller VA; Azzoli CG
    Chest; 2007 Sep; 132(3):1042-4. PubMed ID: 17873198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.